R

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Senior Manager - Clinical Biomarker Operations

Clinical Research OperationsConfirmed live in the last 24 hours
Full-timeRedwood City, CA, USARemote

About the Job

Requirements

  • A Master of Science or PhD in life sciences or a related scientific, medical, or healthcare discipline.
  • At least 10 years of experience in project management and/or related professional experience in a clinical research setting or clinical/diagnostic laboratories.
  • Experience managing and mentoring team members.
  • A proven track record of effective leadership and people management, creating a collaborative environment that fosters productivity and cohesiveness.
  • Excellent scientific and business communication skills, interpersonal and collaboration skills, and planning skills.
  • Strong attention to detail, organizational skills, and time management skills.
  • Ability to think critically and creatively, and work independently to determine appropriate resources for resolving problems.
  • Ability to multitask, adapt, and thrive in a fast-paced, innovative environment with changing priorities.
  • Proficiency in Microsoft Office applications, including Word, Excel, Project, and PowerPoint.
  • Commitment to Revolution Medicines’ Core Values: Tireless Commitment to Patients, Transformative Science, Exceptional Together, Total Integrity, Inclusiveness and Fairness.

Responsibilities

  • Provide biomarker operational expertise, develop scopes of work, and maintain effective working relationships with cross-functional teams supporting Phase I–III clinical trials.
  • Operationalize biomarker program strategies in clinical trials to support early- and late-stage development of portfolio assets.
  • Lead end-to-end biomarker operations across Phase I–III oncology clinical trials, including protocol reviews, prospective testing strategies, sample lifecycle oversight, data management, query resolution, and vendor qualification and contracting.
  • Collaborate with biomarker, bioinformatics, and companion diagnostic scientists on reviews of protocols, informed consent forms, electronic case report forms, data transfer specifications, Genomic Verification Forms, and electronic trial master file documentation to ensure operational alignment and successful collection and testing of clinical trial samples.
  • Work with biomarker scientists to oversee development of statements of work, budgets, timelines, risk management, and vendor management across active studies.
  • Contribute to central laboratory operations, including laboratory startup, review of laboratory manuals and site requisition forms, statement-of-work review, and budget evaluation.
  • Collaborate with Clinical Development, Clinical Operations, Data Management, Quality Assurance, Regulatory Affairs, Procurement, and other functions to ensure operational feasibility and delivery aligned with clinical trial timelines.
  • Collaborate with diagnostic partners and internal cross-functional team members to ensure successful management of companion diagnostic samples.
  • Lead biomarker vendor selection, qualification, onboarding, and oversight; participate in vendor audits to assess adherence to regulatory and quality standards; and provide day-to-day operational management to ensure delivery against contracted scopes of work.
  • Collaborate with Clinical Operations and the Biospecimen Management group to manage sample shipment, storage, and destruction, as applicable.
  • Oversee specialty biomarker laboratory relationships, including sample logistics, alignment of testing strategies, execution of research-use-only data transfers, issue and query resolution, invoice review, and recurring operational meetings.
  • Support real-time sample tracking, data integration, and timely query resolution using interactive response technology and electronic data capture systems, when applicable.
  • Ensure study adherence to International Council for Harmonisation Good Clinical Practice guidelines, standard operating procedures, best practices, and ethical guidelines.
  • Oversee biomarker-related ethics committee and institutional review board inquiries to ensure accurate and consistent responses across studies.
  • Support Translational Medicine deliverables, including data reviews, clinical study reports, audits, and regulatory submissions for companion diagnostic filings.
  • Manage and mentor junior Clinical Biomarker Operations Leads responsible for early- and late-stage clinical trials and day-to-day oversight of contract research organizations, ensuring timely, high-quality delivery.
  • Serve as a subject matter expert and owner for one or more biomarker-related processes within the Clinical Biomarker Operations sub-function, lead standard operating procedure development and operational process optimization, and contribute to biomarker program initiatives that improve operational quality and efficiency.
  • Provide biomarker operational metrics and study updates to cross-functional teams and senior leadership to inform strategic decisions, identify risks, and guide corrective actions.

Desired Qualifications

  • Prior experience in clinical biomarker and companion diagnostic operations across Phase I–III oncology clinical trials, including diagnostic operations supporting companion diagnostic development and regulatory filings.
  • Experience using other project management tools.
  • Project Management Professional certification.
  • Experience with TruTech, SLOPE, and laboratory information management systems for sample management.
  • Experience with next-generation sequencing methods for RAS mutation analysis.

About the Company

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Revolution Medicines develops precision oncology drugs focused on cancers driven by RAS mutations. Its RAS(ON) inhibitors are small molecules that bind the active form of RAS to block cancer signaling, with candidates like Daraxonrasib (RMC-6236), Elironrasib (RMC-6291), and Zoldonrasib (RMC-9805) advancing in global Phase 3 trials. The company funds its research through collaborations, royalties, and upfront funding, and has not yet marketed a product. Its goal is to bring effective RAS-targeted therapies to patients and advance multiple candidates through late-stage trials toward approval, supported by strong cash reserves.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Redwood City, CA
Founded
2014

Recently Posted Jobs

Explore more opportunities at Revolution Medicines

See more jobs